In preparation for the addition of other conditions, development of a multiplex assay for SCID, SMA, and X-linked agammaglobulinemia (XLA) was reported [745] along with a MS/MS procedure for galactose-1-phosphate, reportedly superior to the traditional GALT enzyme analysis [746]. This evidence concerns the gene GALT and Bruton-type agammaglobulinemia.